Literature DB >> 28255419

Delirium following fesoterodine treatment for urgency incontinence in an 89-year old man.

Jeannie Medeiros Charbonneau1, Rania Bisset1, Patrick Viet-Quoc Nguyen2.   

Abstract

We describe the case of an 89-year-old man who developed delirium following the introduction of fesoterodine to treat his urgency incontinence. The patient started experiencing visual hallucinations approximately five days after starting fesoterodine 4 mg once daily. Delirium resolved after fesoterodine was stopped. Despite the apparent safe cognitive profile due to its pharmacodynamic properties, fesoterodine should be used with caution in the elderly, frail population.

Entities:  

Year:  2016        PMID： 28255419      PMCID： PMC5325757          DOI： 10.5489/cuaj.3697

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


  24 in total

1.  Evaluation of cognitive function in healthy older subjects treated with fesoterodine.

Authors:  Gary G Kay; Paul Maruff; David Scholfield; Bimal Malhotra; Laurence Whelan; Amanda Darekar; Diane L Martire
Journal:  Postgrad Med       Date:  2012-05       Impact factor: 3.840

2.  Validation of the Delirium Rating Scale-revised-98: comparison with the delirium rating scale and the cognitive test for delirium.

Authors:  P T Trzepacz; D Mittal; R Torres; K Kanary; J Norton; N Jimerson
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

Review 3.  Delirium in elderly people.

Authors:  Sharon K Inouye; Rudi G J Westendorp; Jane S Saczynski
Journal:  Lancet       Date:  2013-08-28       Impact factor: 79.321

4.  Severe anticholinergic drug-induced delirium in a young adult after renal transplantation.

Authors:  Angela K Götz; Stephan W Reinhold; Alexander Szecsey; Bernhard Banas; Bernhard K Krämer
Journal:  Transpl Int       Date:  2008-09-09       Impact factor: 3.782

Review 5.  Fesoterodine clinical efficacy and safety for the treatment of overactive bladder in relation to patient profiles: a systematic review.

Authors:  Christopher Chapple; Matthias Oelke; Steven A Kaplan; David Scholfield; Daniel Arumi; Adrian S Wagg
Journal:  Curr Med Res Opin       Date:  2015-04-23       Impact factor: 2.580

6.  Psychotic disorder induced by oxybutynin: Presentation of two cases.

Authors:  Murat Gulsun; Murat Pinar; Unal Sabanci
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

Review 7.  The Confusion Assessment Method: a systematic review of current usage.

Authors:  Leslie A Wei; Michael A Fearing; Eliezer J Sternberg; Sharon K Inouye
Journal:  J Am Geriatr Soc       Date:  2008-04-01       Impact factor: 5.562

8.  Flexible-dose fesoterodine in elderly adults with overactive bladder: results of the randomized, double-blind, placebo-controlled study of fesoterodine in an aging population trial.

Authors:  Adrian Wagg; Vik Khullar; Daniela Marschall-Kehrel; Martin C Michel; Matthias Oelke; Amanda Darekar; Caty E Bitoun; David Weinstein; Ian Osterloh
Journal:  J Am Geriatr Soc       Date:  2013-01-25       Impact factor: 5.562

Review 9.  Delirium in elderly adults: diagnosis, prevention and treatment.

Authors:  Tamara G Fong; Samir R Tulebaev; Sharon K Inouye
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

10.  Pharmacokinetic profile of fesoterodine.

Authors:  B Malhotra; Z Guan; N Wood; K Gandelman
Journal:  Int J Clin Pharmacol Ther       Date:  2008-11       Impact factor: 1.366
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.